Keith Regnante Keros Therapeutics, Inc. (KROS) insider trading activity

KROS Quotes by TradingView

Keith Regnante is CHIEF FINANCIAL OFFICER of Keros Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KROS, which is worth approximately $0. The most recent transaction as insider was on Nov 04, 2023, when has been sold 40,000 shares (Common Stock) at a price of $45.29 per share, resulting in proceeds of $1,811,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Keith Regnante Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 04 2023
SELL
Open market or private sale
$1,811,600 $45.29 p/Share
40,000 Reduced 100.0%
0 Common Stock
Nov 04 2023
BUY
Exercise of conversion of derivative security
$640,000 $16.0 p/Share
40,000 Added 50.0%
40,000 Common Stock
Jun 09 2023
SELL
Open market or private sale
$925,000 $46.25 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jun 09 2023
BUY
Exercise of conversion of derivative security
$320,000 $16.0 p/Share
20,000 Added 50.0%
20,000 Common Stock
Jun 08 2023
SELL
Open market or private sale
$963,199 $48.16 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jun 08 2023
BUY
Exercise of conversion of derivative security
$320,000 $16.0 p/Share
20,000 Added 50.0%
20,000 Common Stock
KR

Keith Regnante

CHIEF FINANCIAL OFFICER
Lexington, MA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS